SHANGHAI--(BUSINESS WIRE)--Generon BioMed Holding Ltd. (Generon), announced today at the annual San Antonio Breast Cancer Symposium (SABCS), positive results from a placebo-controlled trial with F-627 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results